Purpose: To make recommendations regarding the use of bisphosphonates and other bone-
modifying agents as adjuvant therapy for patients with breast cancer. Methods: Cancer Care …

Background: Osteoporosis is a major contributor to the propensity to fracture among older
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Purpose: Non-infectious uveitis is a leading cause of vision loss in the developed world. The
purpose of this systematic review is to investigate the epidemiology and risk factors of non …

Abstract Purpose of Review The aim of this review is to provide the information necessary for
recognizing scleritis in rheumatology patients, recognize associated systemic diseases in …

Objective. To estimate the future risk and time trends of venous thromboembolism (VTE) in
individuals with newly diagnosed primary Sjögren syndrome (pSS) in the general …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …

Abstract Background Bisphosphonates (BPs) are pyrophosphate analogues widely used in
diseases related to bone loss and increased bone turnover. Their high affinity for bone …

Osteoporosis remains an important but underappreciated disorder. In the United States,
there are at least 2 million osteoporotic fractures every year. Vertebral fractures are the most …